{
    "ticker": "XBI",
    "name": "SPDR S&P Biotech ETF",
    "description": "The SPDR S&P Biotech ETF (XBI) is an exchange-traded fund that seeks to provide investors with exposure to the biotechnology sector of the S&P Total Market Index. Launched in 2006, XBI is designed to track the performance of biotechnology companies, which are engaged in the research, development, and commercialization of innovative drugs and therapies. The fund is unique in its equal-weighted approach, allowing for diversified exposure across a broad range of biotech firms, from large-cap leaders to smaller, emerging companies. This structure mitigates the risks associated with concentration on a handful of large companies and enhances potential growth opportunities across the entire sector. XBI includes companies involved in various biopharmaceutical fields, including gene therapy, monoclonal antibodies, and personalized medicine. The ETF is a popular choice for investors seeking to capitalize on the advancements in medical science and the ongoing demand for new treatments. With a focus on innovation and development, the biotechnology sector is seen as a critical component of healthcare, making XBI an attractive investment for those looking to gain exposure to this dynamic market.",
    "industry": [
        "Biotechnology",
        "Healthcare"
    ],
    "headquarters": "Boston, Massachusetts, USA",
    "founded": "2006",
    "website": "https://www.ssga.com/us/en/individual/etfs/funds/spdr-s-and-p-biotech-etf-xbi",
    "key_executives": [
        {
            "name": "State Street Global Advisors",
            "position": "Investment Manager"
        }
    ],
    "product_categories": [
        {
            "category": "Biotechnology Stocks",
            "products": [
                "Gene Therapy",
                "Monoclonal Antibodies",
                "Personalized Medicine"
            ]
        }
    ],
    "seo": {
        "meta_title": "SPDR S&P Biotech ETF (XBI) | Invest in Biotechnology Sector",
        "meta_description": "Invest in the biotechnology sector with the SPDR S&P Biotech ETF (XBI). Discover opportunities in innovative drug development and cutting-edge therapies.",
        "keywords": [
            "XBI",
            "Biotechnology ETF",
            "Healthcare Investment",
            "Biotech Stocks",
            "SPDR Funds"
        ]
    },
    "faq": [
        {
            "question": "What is XBI?",
            "answer": "XBI is the SPDR S&P Biotech ETF that offers exposure to the biotechnology sector."
        },
        {
            "question": "What is the investment strategy of XBI?",
            "answer": "XBI uses an equal-weighted strategy to invest in a diverse range of biotechnology companies."
        },
        {
            "question": "When was XBI founded?",
            "answer": "XBI was founded in 2006."
        },
        {
            "question": "What types of companies are included in XBI?",
            "answer": "XBI includes companies involved in gene therapy, monoclonal antibodies, and personalized medicine."
        },
        {
            "question": "Who manages XBI?",
            "answer": "XBI is managed by State Street Global Advisors."
        }
    ],
    "competitors": [
        "IBB",
        "XLC",
        "XLV"
    ],
    "related_stocks": [
        "AAPL",
        "AMGN",
        "GILD",
        "VRTX"
    ]
}